25 November 2022 Achiko AG issues a convocation notice to its shareholders for its Annual General Meeting on 20 December 2022
3 October 2022 Ad-hoc Announcement: Achiko AG reports first half to 30 June 2022 results and provides corporate update as of 30 September 2022
31 August 2022 Ad-hoc Announcement: Achiko AG Announces Newly Published Annual Report and Accounts for the Year Ended 31 December 2021
9 August 2022 Ad-hoc Announcement: Achiko AG – Achiko to publish its 2021 Annual Report by 31 August 2022
26 June 2022 Ad-hoc Announcement: Achiko AG Announces Annual Results for the Year Ended 31 December 2021
20 June 2022 Ad-hoc Announcement: Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by 26 June 2022
10 June 2022 Ad-hoc Announcement: Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by 20 June 2022
6 June 2022 Ad-hoc Announcement: Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by 10 June 2022
31 May 2022 Ad-hoc Announcement: Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by 6 June 2022
25 May 2022 Ad-hoc Announcement: Achiko AG Secures CHF 1.25 million Financing with Strategic Investors Buranto AG and Negma Group
19 May 2022 Ad-hoc Announcement: Achiko AG Reports Key Unaudited Financial Results for the Year Ended 31 December 2021
29 April 2022 Ad-hoc Announcement: Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by 31 May 2022
20 April 2022 Ad-hoc Announcement: Achiko AG Signs Major Marketing and Sales Agreement with the World’s Largest Islamic Association for its AptameX Covid-19 rapid test
20 April 2022 Ad-hoc Announcement: Achiko secures up to CHF12m equity and debt financing lines with RiverFort over 3 years
27 January 2022 Ad-hoc Announcement: Achiko AG strengthens senior team with appointment of Head of Corporate Development
14 January 2022 Ad-hoc Announcement: Achiko AG Reports Breakthrough Calibration Results for AptameX Covid-19 Rapid Test Technology